SWKH - NASDAQ

SWK Holdings Corporation

SWKH·NASDAQ

$15.90

+0.0000%

Financial ServicesAsset Management

SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. In addition, the company engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Further, it intends to out-license its internal product pipeline to create novel formulations using its proprietary technology to develop treatments for patients and caregivers. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$192.33M

EPS-0.2100

P/E Ratio-82.58

Earnings Date05/11/2026

272.42M

Assets

-18%

3Y-9.0%

5Y-1.0%

10Y+30.0%

37.32M

Total Liabilities

-14%

3Y+90.0%

5Y+12.0%

10Y+4185.0%

235.10M

Total Equity

-19%

3Y-16.0%

5Y-2.0%

10Y+13.0%

SWK Holdings Corporation Funding & Solvency Profile

SWKH · NASDAQ

Current Assets

Cash & Cash Equivalents42.76M

Net Receivables3.86M

Inventory0.00

Other Current Assets163.00K

Total Current Assets47 M

Non-Current Assets

Property, Plant & Equipment0.00

Goodwill & Intangible Assets0.00

Long-Term Investments184.00K

Other Non-Current Assets224.54M

Total Non-Current Assets225 M

Total Assets

272.42M

Financial Health Analysis

Current Ratio

9.41x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.16x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

42 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

17% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

SWK Holdings Corporation Balance Sheet

SWKH • NASDAQ

SWK Holdings Corporation Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	42.8M	5.9M	4.5M	6.2M	42.9M	3M	11.2M	20.2M	30.6M	32.2M	47.3M	58.7M	7.7M	24.6M	38.2M	39.3M	38.6M	7M	4.3M	5.7M
Short-Term Investments	0.0	0.0	0.0	0.0	1M	1.2M	1.8M	532K	1.9M	2.6M	5.3M	4.8M	3.1M	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cash & Short-Term Investments	42.8M	5.9M	4.5M	6.2M	43.9M	4.2M	13M	20.2M	30.6M	32.2M	47.3M	58.7M	7.7M	24.6M	38.2M	39.3M	38.6M	7M	4.3M	5.7M
Net Receivables	3.9M	5.8M	4.7M	3.1M	1.8M	1.9M	2.6M	168.8M	153.6M	127.4M	100.5M	94.4M	1.2M	427K	0.0	0.0	0.0	7.6M	10.2M	8.8M
Accounts Receivables	3.9M	5.8M	4.7M	3.1M	1.8M	1.9M	2.6M	0.0	153.6M	127.4M	100.5M	94.4M	1.2M	427K	0.0	0.0	1.4M	7.6M	10.2M	8.8M
Other Receivables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	168.8M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Inventory	0.0	0.0	0.0	0.0	0.0	0.0	0.0	532K	1.9M	2.6M	5.3M	4.8M	3.1M	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Prepaids	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19K	16K	36K	66K	63K	1.5M	2M	2.4M	2M
Other Current Assets	163K	8.5M	2.6M	1.1M	1.7M	542K	1.1M	0.0	0.0	0.0	0.0	362K	687K	1M	0.0	0.0	28K	0.0	0.0	74K
Total Current Assets	46.8M	20.3M	11.9M	10.4M	47.4M	6.7M	16.6M	189M	184.2M	159.6M	147.8M	71.4M	9.6M	26M	38.3M	39.3M	40.1M	16.6M	16.9M	16.5M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	0.0	48K	5.4M	5.8M	5.8M	5.2M	1.3M	25K	-22.7M	-38.5M	0.0	0.0	5K	3K	4K	6K	0.0	1.9M	2.3M	1.2M
Goodwill	0.0	0.0	0.0	8.4M	8.4M	8.4M	8.4M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4M	12.5M	8.6M
Intangible Assets	0.0	0.0	6.5M	8.2M	10M	13.5M	25.1M	0.0	153.6M	127.4M	0.0	0.0	1.2M	0.0	0.0	0.0	0.0	1.7M	2.2M	15K
Goodwill & Intangible Assets	0.0	0.0	6.5M	16.6M	18.4M	21.9M	33.5M	-25K	22.7M	38.5M	0.0	0.0	28.6M	0.0	0.0	0.0	0.0	14.1M	14.7M	8.6M
Long-Term Investments	184K	580K	48K	76K	3.6M	3.7M	466K	532K	1.9M	9.6M	13.3M	13.9M	13.5M	13M	0.0	0.0	0.0	0.0	0.0	0.0
Tax Assets	912K	23.5M	28.3M	24.5M	20.5M	27.5M	25.8M	22.7M	22.7M	38.5M	16.8M	19.4M	9.6M	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Assets	224.5M	287.9M	282.1M	242.3M	186.9M	208.9M	176.7M	3.4M	1.1M	1.3M	2.6M	83.5M	206K	6.3M	0.0	0.0	0.0	1.2M	1.4M	4M
Total Non-Current Assets	225.6M	312M	322.4M	289.3M	235.2M	267.2M	237.8M	26.6M	25.7M	49.3M	32.7M	116.8M	52M	19.3M	4K	6K	0.0	17.2M	18.5M	13.8M
Total Assets	272.4M	332.2M	334.3M	299.6M	282.7M	273.9M	254.4M	215.7M	209.9M	208.9M	180.5M	188.2M	61.6M	45.3M	38.3M	39.3M	40.1M	33.8M	35.4M	30.3M
LIABILITIES
CURRENT LIABILITIES
Total Payables	0.0	0.0	0.0	0.0	5.1M	3.7M	17.6M	2.6M	0.0	0.0	241K	48K	59K	32K	177K	23K	0.0	3.6M	3.1M	2.7M
Accounts Payable	0.0	0.0	0.0	0.0	5.1M	3.7M	3.1M	2.6M	0.0	0.0	241K	48K	59K	32K	177K	0.0	0.0	3.6M	3.1M	2.7M
Other Payables	0.0	0.0	0.0	0.0	0.0	0.0	-3.1M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23K	0.0	0.0	0.0	0.0
Accrued Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	547K	816K	254K	11K	10K	178K	285K	6.1M	6.6M	8.7M
Short Term Debt	0.0	0.0	0.0	2.4M	8K	11.8M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8M	3M	327K
Deferred Revenue	0.0	1.5M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50K	48K	0.0	0.0	0.0	12.9M	15.8M	15.8M
Other Current Liabilities	5M	4.1M	3.9M	3.9M	0.0	0.0	-14.5M	11K	0.0	0.0	-788K	-1K	-363K	0.0	0.0	30K	0.0	0.0	0.0	0.0
Total Current Liabilities	5M	5.6M	3.9M	6.3M	5.1M	15.4M	17.6M	2.6M	1.8M	682K	788K	863K	363K	91K	187K	231K	285K	30.4M	28.6M	27.6M
NON-CURRENT LIABILITIES
Long Term Debt	32.1M	37.6M	43.1M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5M	0.0	0.0	0.0	0.0	13K	0.0	0.0
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	17.8M	2.6M	1.9M	871K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86K	297K	410K
Deferred Tax Liabilities (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	-17.8M	186.4M	182.3M	158.7M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	234K	0.0	0.0
Other Non-Current Liabilities	240K	335K	6.9M	13.3M	10.3M	18M	17.8M	0.0	0.0	0.0	0.0	1.3M	658K	1M	63K	89K	109K	479K	2.1M	5.5M
Total Non-Current Liabilities	32.4M	38M	50M	13.3M	10.3M	18M	279K	13K	91K	189K	259K	422K	5.3M	1M	63K	89K	109K	812K	2.4M	5.9M
Total Liabilities	37.3M	43.5M	53.9M	19.7M	15.4M	33.4M	17.8M	2.6M	1.9M	871K	1M	1.3M	5.7M	1.1M	250K	320K	394K	31.2M	31M	33.5M
SHAREHOLDERS' EQUITY
Common Stock	12K	12K	12K	12K	13K	13K	13K	13K	13K	13K	13K	131K	43K	43K	42K	42K	41K	41K	41K	36K
Additional Paid-In Capital	4.4B	4.4B	4.4B	4.4B	4.4B	4.4B	4.4B	4.4B	4.4B	4.4B	4.4B	4.4B	4.3B	4.3B	4.3B	4.3B	4.3B	4.3B	4.3B	4.3B
Retained Earnings	-4.2B	-4.1B	-4.1B	-4.2B	-4.2B	-4.2B	-4.2B	-4.2B	-4.2B	-4.2B	-4.3B	-4.3B	-4.3B	-4.3B	-4.3B	-4.3B	-4.3B	-4.3B	-4.3B	-4.3B
Accumulated Other Comprehensive Income/Loss	0.0	0.0	0.0	0.0	0.0	0.0	0.0	213.1M	213K	-87K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-684K	638K	171K
Total Stockholders' Equity	235.1M	288.7M	280.3M	279.9M	267.2M	240.5M	236.5M	213.1M	208M	204.3M	175.1M	182.1M	50.3M	37.2M	38M	39M	39.7M	2.6M	4.4M	-3.1M
Total Equity	235.1M	288.7M	280.3M	279.9M	267.2M	240.5M	223.6M	192.8M	177.4M	208.1M	179.4M	186.9M	55.9M	44.2M	38M	39M	39.7M	2.6M	4.4M	-3.1M
Minority Interest	0.0	0.0	0.0	0.0	0.0	0.0	-13M	-20.2M	-30.6M	3.8M	4.3M	4.9M	5.6M	7M	0.0	0.0	0.0	0.0	0.0	0.0
SUMMARY
Total Liabilities & Equity	272.4M	332.2M	334.3M	299.6M	282.7M	273.9M	254.4M	215.7M	209.9M	208.9M	180.5M	188.2M	61.6M	45.3M	38.3M	39.3M	40.1M	33.8M	35.4M	30.3M
Total Investments	184K	580K	48K	76K	4.6M	4.9M	2.3M	1.1M	3.7M	12.2M	18.6M	18.7M	16.7M	13M	0.0	0.0	0.0	0.0	0.0	0.0
Total Debt	32.1M	37.6M	43.1M	2.4M	8K	11.8M	76K	13K	91K	189K	259K	421K	5M	0.0	0.0	0.0	0.0	7.8M	3M	327K
Net Debt	-10.7M	31.7M	38.6M	-3.7M	-42.9M	8.8M	-11.1M	-20.2M	-30.5M	-32M	-47M	-58.3M	-2.7M	-24.6M	-38.2M	-39.3M	-38.6M	846K	-1.3M	-5.4M
Shares Outstanding	12,245,171	12,245,171	12,245,171	12,245,171	12,245,171	12,245,171	12,245,171	12,245,171	12,245,171	12,245,171	12,245,171	12,245,171	12,245,171	12,245,171	12,245,171	12,245,171	12,245,171	12,245,171	12,245,171	12,245,171

SEC Filings

SWKH - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	April 06, 2026	April 06, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 31, 2026	March 31, 2026	2026	View Filing
10-K 10-K 2025 FY FY	March 20, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 13, 2026	February 13, 2026	2026	View Filing
8-K 8-K 2025 N/A	December 05, 2025	December 04, 2025	2025	View Filing
8-K 8-K 2025 N/A	December 04, 2025	December 02, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 06, 2025	November 06, 2025	2025	View Filing
10-Q 10-Q 2025 Q3 Q3	November 06, 2025	September 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	October 10, 2025	October 09, 2025	2025	View Filing
8-K 8-K 2025 N/A	October 09, 2025	October 09, 2025	2025	View Filing

Showing 1 to 10 of 497 filings

Related Guides

Blog Categories

Continue your SWKH research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.